{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:57:41Z","timestamp":1761544661423,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012297","name":"Society of Family Planning","doi-asserted-by":"publisher","award":["SFPRFSS19-15"],"award-info":[{"award-number":["SFPRFSS19-15"]}],"id":[{"id":"10.13039\/100012297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.japh.2022.02.013","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T18:03:06Z","timestamp":1645552986000},"page":"1296-1303.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Twelve-month supply of short-acting contraception methods: Pharmacists\u2019 perspectives on implementation of new state law"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5957-2367","authenticated-orcid":false,"given":"Neena","family":"Qasba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8088-0508","authenticated-orcid":false,"given":"Kate F.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Sopko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Czajka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kam L.","family":"Capoccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Shcherbakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Goff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2022.02.013_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40834-020-00118-5","article-title":"Are higher unintended pregnancy rates among minorities a result of disparate access to contraception?","volume":"5","author":"Troutman","year":"2020","journal-title":"Contracept Reprod Med"},{"issue":"5","key":"10.1016\/j.japh.2022.02.013_bib6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/01.AOG.0000239122.98508.39","article-title":"Number of oral contraceptive pill packages dispensed, method continuation, and costs","volume":"108","author":"Foster","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.japh.2022.02.013_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/AOG.0b013e3182056309","article-title":"Number of oral contraceptive pill packages dispensed and subsequent unintended pregnancies","volume":"117","author":"Foster","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.japh.2022.02.013_bib8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jamainternmed.2019.1678","article-title":"Financial implications of 12-month dispensing of oral contraceptive pills in the Veterans Affairs Health Care System [published correction appears in JAMA Intern Med. 2019;179(3):1303]","volume":"179","author":"Judge-Golden","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"9391","key":"10.1016\/j.japh.2022.02.013_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients\u2019 care","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.japh.2022.02.013_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6963-5-53","article-title":"Implementation of a health care policy: an analysis of barriers and facilitators to practice change","volume":"5","author":"Watt","year":"2005","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.japh.2022.02.013_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.japh.2019.07.018","article-title":"Pharmacists as women\u2019s health providers: increasing access to contraception and preconception care","volume":"59","author":"Mospan","year":"2019","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2022.02.013_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1748-5908-7-37","article-title":"Validation of the theoretical domains framework for use in behaviour change and implementation research","volume":"7","author":"Cane","year":"2012","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.japh.2022.02.013_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1748-5908-7-35","article-title":"Theories of behaviour change synthesised into a set of theoretical groupings: introducing a thematic series on the theoretical domains framework","volume":"7","author":"Francis","year":"2012","journal-title":"Implement Sci"},{"issue":"12","key":"10.1016\/j.japh.2022.02.013_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010009","article-title":"Protocol for ACCESS: a qualitative study exploring barriers and facilitators to accessing the emergency contraceptive pill from community pharmacies in Australia","volume":"5","author":"Hussainy","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.japh.2022.02.013_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/160940690600500103","article-title":"The development of constructivist grounded theory","volume":"5","author":"Mills","year":"2006","journal-title":"Int J Qual Methods"},{"issue":"1","key":"10.1016\/j.japh.2022.02.013_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13012-020-01007-w","article-title":"Quantitative measures of health policy implementation determinants and outcomes: a systematic review","volume":"15","author":"Allen","year":"2020","journal-title":"Implement Sci"},{"issue":"6","key":"10.1016\/j.japh.2022.02.013_bib20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.japh.2020.07.019","article-title":"Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies","volume":"60","author":"Chen","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.japh.2022.02.013_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/pharmacy7030096","article-title":"Pharmacist outlooks on prescribing hormonal contraception following statewide scope of practice expansion","volume":"7","author":"Rafie","year":"2019","journal-title":"Pharmacy (Basel)"},{"issue":"3","key":"10.1016\/j.japh.2022.02.013_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/pharmacy8030165","article-title":"Pharmacy implementation of a new law allowing year-long hormonal contraception supplies","volume":"8","author":"Nikpour","year":"2020","journal-title":"Pharmacy (Basel)"},{"issue":"3","key":"10.1016\/j.japh.2022.02.013_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/03630242.2019.1635561","article-title":"Facilitators and barriers to implementing pharmacist-prescribed hormonal contraception in California independent pharmacies","volume":"60","author":"Gomez","year":"2020","journal-title":"Women Health"},{"issue":"4","key":"10.1016\/j.japh.2022.02.013_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6504a1","article-title":"U.S. Selected Practice Recommendations for Contraceptive Use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.japh.2022.02.013_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5252","article-title":"Association of pharmacist prescription with dispensed duration of hormonal contraception","volume":"3","author":"Rodriguez","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.japh.2022.02.013_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.japh.2021.08.010","article-title":"Impact of pharmacist prescribing through direct pharmacy access policies on access to hormonal contraception","volume":"62","author":"Beal","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:50:02Z","timestamp":1761544202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319122000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1544319122000668"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2022.02.013","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twelve-month supply of short-acting contraception methods: Pharmacists\u2019 perspectives on implementation of new state law","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2022.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}